Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX/COVID-12 “Patria” recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico
Titel:
Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX/COVID-12 “Patria” recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico
Auteur:
López-Macías, Constantino Torres, Martha Armenta-Copca, Brenda Wacher, Niels H. Castro-Castrezana, Laura Colli-Domínguez, Andrea Alicia Rivera-Hernández, Tania Torres-Flores, Alejandro Damián-Hernández, Matilde Ramírez-Martínez, Luis la Rosa, Georgina Paz-De Rojas-Martínez, Oscar Suárez-Martínez, Alejandro Peralta-Sánchez, Gustavo Carranza, Claudia Juárez, Esmeralda Zamudio-Meza, Horacio Carreto-Binaghi, Laura E. Viettri, Mercedes Romero-Rodríguez, Damaris Palencia, Andrea Reyna-Rosas, Edgar Márquez-García, José E. Sarfati-Mizrahi, David Sun, Weina Chagoya-Cortés, Héctor Elías Castro-Peralta, Felipa Palese, Peter Krammer, Florian García-Sastre, Adolfo Lozano-Dubernard, Bernardo